HEFEI XUANZHONGQIAO E-COMMERCE CO., LTD – Trademark Portfolio

Entity Type: 99

HEFEI XUANZHONGQIAO E-COMMERCE CO., LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include HWTONG. The owner is based in HEFEI CITY, ANHUI PROVINCE.

ROOM 1705, BUILDING A, GREENLAND CENTER

SUSONG ROAD, BAOHE DISTRICT

HEFEI CITY, ANHUI PROVINCE 230000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

HWTONG
HWTONG
Registered 2022

Trademark Classifications

HEFEI XUANZHONGQIAO E-COMMERCE CO., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does HEFEI XUANZHONGQIAO E-COMMERCE CO., LTD have?

HEFEI XUANZHONGQIAO E-COMMERCE CO., LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does HEFEI XUANZHONGQIAO E-COMMERCE CO., LTD file in?

HEFEI XUANZHONGQIAO E-COMMERCE CO., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are HEFEI XUANZHONGQIAO E-COMMERCE CO., LTD's most well-known trademarks?

HEFEI XUANZHONGQIAO E-COMMERCE CO., LTD's registered trademark portfolio includes well-known marks such as HWTONG. These are among 1 currently registered trademark in the portfolio.

What is HEFEI XUANZHONGQIAO E-COMMERCE CO., LTD's trademark registration success rate?

HEFEI XUANZHONGQIAO E-COMMERCE CO., LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.